These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12754425)

  • 1. [Intestinal mucosa immunity and oral vaccines especially regarding E. coli vaccines: a review].
    Aiuti F; Iebba F
    Infez Med; 2002 Dec; 10(4):191-203. PubMed ID: 12754425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
    Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
    Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.
    Daley A; Randall R; Darsley M; Choudhry N; Thomas N; Sanderson IR; Croft NM; Kelly P
    Gut; 2007 Nov; 56(11):1550-6. PubMed ID: 17566016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunity: implications for vaccine development.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system.
    McGhee JR; Kiyono H; Michalek SM; Mestecky J
    Antonie Van Leeuwenhoek; 1987; 53(6):537-43. PubMed ID: 3329827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut.
    Shikina T; Hiroi T; Iwatani K; Jang MH; Fukuyama S; Tamura M; Kubo T; Ishikawa H; Kiyono H
    J Immunol; 2004 May; 172(10):6259-64. PubMed ID: 15128814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.
    Czerkinsky C; Svennerholm AM; Holmgren J
    Clin Infect Dis; 1993 Mar; 16 Suppl 2():S106-16. PubMed ID: 8452962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization.
    Verdonck F; Joensuu JJ; Stuyven E; De Meyer J; Muilu M; Pirhonen M; Goddeeris BM; Mast J; Niklander-Teeri V; Cox E
    Vaccine; 2008 Oct; 26(45):5728-35. PubMed ID: 18762221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
    Ruan X; Zhang W
    Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
    Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
    Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there evidence that the gut contributes to mucosal immunity in humans?
    Kang W; Kudsk KA
    JPEN J Parenter Enteral Nutr; 2007; 31(3):246-58. PubMed ID: 17463152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against enteric bacterial diseases.
    Hone D; Hackett J
    Rev Infect Dis; 1989; 11(6):853-77. PubMed ID: 2690285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunity and vaccination.
    Holmgren J
    FEMS Microbiol Immunol; 1991 Dec; 4(1):1-9. PubMed ID: 1815705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
    Oliveira AF; Cardoso SA; Almeida FB; de Oliveira LL; Pitondo-Silva A; Soares SG; Hanna ES
    Microbiol Immunol; 2012 Aug; 56(8):513-22. PubMed ID: 22671942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-associated lymphoid tissue as source of an IgA immune response in respiratory tissues after oral immunization and intrabronchial challenge.
    Weisz-Carrington P; Grimes SR; Lamm ME
    Cell Immunol; 1987 Apr; 106(1):132-8. PubMed ID: 3568143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
    Pascual DW; Powell RJ; Lewis GK; Hone DM
    Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell functions in the inductive and effector sites of intestinal immunity.
    Luciani C; Hager FT; Cerovic V; Lelouard H
    Mucosal Immunol; 2022 Jan; 15(1):40-50. PubMed ID: 34465895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.